Europe’s biotechnology industry is finally beginning to catch up with the US,
according to the international consultancy Ernst & Young. Ken Lee, coauthor
of Ernst & Young’s annual snapshot of the industry, says that the US, with
1287 biotech companies in April 1997, still has the lead, although this figure
represents a drop of 2 per cent on the previous year. But Europe is expanding
rapidly, boasting 716 companies compared to 584 the year before.
More from New Scientist
Explore the latest news, articles and features
Popular articles
Trending New Scientist articles


